Revolution Medicines, Inc.
US ˙ NasdaqGS ˙ US76155X1000

SecurityRVMD / Revolution Medicines, Inc.
InstitutionBessemer Group Inc
Latest Disclosed Ownership48,062 shares
Latest Disclosed Value $ 4,675
Bessemer Group Inc reports 59.15% decrease in ownership of RVMD / Revolution Medicines, Inc.

On May 6, 2026 - Bessemer Group Inc filed a 13F-HR form disclosing ownership of 48,062 shares of Revolution Medicines, Inc. (US:RVMD) valued at $4,674,030 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 5, 2026 disclosing 117,662 shares of Revolution Medicines, Inc.. This represents a change in shares of -59.15% during the quarter. The current value of the position is $7,497,191 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-06 2026-03-31 13F REVOLUTION MEDICINES SC 76155X100 48,062 -69,600 -59.15 5 -55.56 0.0073
2026-02-05 2025-12-31 13F REVOLUTION MEDICINES SC 76155X100 117,662 -126,205 -51.75 9 -18.18 0.0144
2025-11-05 2025-09-30 13F REVOLUTION MEDICINES SC 76155X100 243,867 296 0.12 11 37.50 0.0174
2025-08-01 2025-06-30 13F REVOLUTION MEDICINES SC 76155X100 243,571 0 0.00 9 0.00 0.0145
2025-04-23 2025-03-31 13F REVOLUTION MEDICINES SC 76155X100 243,571 13 0.01 9 -20.00 0.0154
2025-02-13 2024-12-31 13F REVOLUTION MEDICINES SC 76155X100 243,558 0 0.00 11 -9.09 0.0174
2024-11-12 2024-09-30 13F REVOLUTION MEDICINES SC 76155X100 243,558 116 0.05 11 22.22 0.0182
2024-08-13 2024-06-30 13F REVOLUTION MEDICINES SC 76155X100 243,442 0 0.00 9 28.57 0.0167
2024-08-13 2024-03-31 13F/A-1 REVOLUTION MEDICINES SC 76155X100 243,442 0 0.00 8 16.67 0.0142
2024-05-13 2024-03-31 13F REVOLUTION MEDICINES SC 76155X100 243,442 0 8 0.0142
2024-02-09 2023-12-31 13F REVOLUTION MEDICINES SC 76155X100 243,442 0 0.00 7 0.00 0.0136
2023-11-13 2023-09-30 13F REVOLUTION MEDICINES SC 76155X100 243,442 -199,000 -44.98 7 -45.45 0.0148
2023-08-10 2023-06-30 13F REVOLUTION MEDICINES SC 76155X100 442,442 0 0.00 12 22.22 0.0251
2023-05-10 2023-03-31 13F REVOLUTION MEDICINES SC 76155X100 442,442 -30,561 -6.46 10 -18.18 0.0227
2023-02-13 2022-12-31 13F REVOLUTION MEDICINES SC 76155X100 473,003 -3,847 -0.81 11 -99.88 0.0274
2022-11-09 2022-09-30 13F REVOLUTION MEDICINES SC 76155X100 476,850 38,796 8.86 9,404 10.14 0.0245
2022-08-10 2022-06-30 13F REVOLUTION MEDICINES SC 76155X100 438,054 0 0.00 8,538 -23.60 0.0213
2022-05-12 2022-03-31 13F REVOLUTION MEDICINES SC 76155X100 438,054 0 0.00 11,175 1.35 0.0234
2022-01-27 2021-12-31 13F REVOLUTION MEDICINES SC 76155X100 438,054 0 0.00 11,026 -8.51 0.0221
2021-11-12 2021-09-30 13F REVOLUTION MEDICINES SC 76155X100 438,054 0 0.00 12,051 -13.33 0.0257
2021-08-06 2021-06-30 13F REVOLUTION MEDICINES SC 76155X100 438,054 0 0.00 13,904 -30.82 0.0302
2021-05-13 2021-03-31 13F REVOLUTION MEDICINES SC 76155X100 438,054 -113,197 -20.53 20,098 -7.91 0.0482
2021-02-09 2020-12-31 13F REVOLUTION MEDICINES SC 76155X100 551,251 -124,167 -18.38 21,824 -7.15 0.0577
2020-11-12 2020-09-30 13F REVOLUTION MEDICINES SC 76155X100 675,418 0 0.00 23,505 10.23 0.0695
2020-08-05 2020-06-30 13F REVOLUTION MEDICINES SC 76155X100 675,418 0 0.00 21,323 44.09 0.0673
2020-04-30 2020-03-31 13F REVOLUTION MEDICINES SC 76155X100 675,418 675,418 14,798 0.0596
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.